Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Role of Lacosamide in Preventing Pentylenetetrazole Kindling-Induced Alterations in the Expression of the Gamma-2 Subunit of the GABAA Receptor in Rats.

Gáll Z, Kelemen K, Mihály I, Salamon P, Miklóssy I, Zsigmond B, Kolcsár M.

Curr Mol Pharmacol. 2020 Jan 1. doi: 10.2174/1874467213666200102095023. [Epub ahead of print]

PMID:
31894752
2.

Temporal Dynamics of Two Pathogenic Hantaviruses Among Rodents in Hungary.

Madai M, Németh V, Oldal M, Horváth G, Herczeg R, Kelemen K, Kemenesi G, Jakab F.

Vector Borne Zoonotic Dis. 2019 Dec 10. doi: 10.1089/vbz.2019.2438. [Epub ahead of print]

PMID:
31821117
3.

HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient.

Guerrero C, Jain T, Kelemen K.

Case Rep Hematol. 2019 Aug 22;2019:4536157. doi: 10.1155/2019/4536157. eCollection 2019.

4.

Vasculitis on brain angiography is not always vasculitis: intravascular large B-cell lymphoma mimicking central nervous system vasculitis.

Rayfield C, Mertz L, Kelemen K, Aslam F.

BMJ Case Rep. 2019 Aug 26;12(8). pii: e230753. doi: 10.1136/bcr-2019-230753.

PMID:
31451471
5.

Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis.

Valencia-Sanchez C, Steenerson KK, Kelemen K, Orenstein R, Kusne S, Grill MF.

J Neurovirol. 2019 Apr;25(2):280-283. doi: 10.1007/s13365-018-0711-8. Epub 2019 Jan 3.

PMID:
30607891
6.

Constitutional chromosome rearrangements that mimic the 2017 world health organization "acute myeloid leukemia with recurrent genetic abnormalities": A study of three cases and review of the literature.

Peterson JF, Pitel BA, Smoley SA, Smadbeck JB, Johnson SH, Vasmatzis G, Pearce KE, He R, Kelemen K, Al-Mondhiry HAB, Lamparella NE, Hoppman NL, Kearney HM, Baughn LB, Ketterling RP, Greipp PT.

Cancer Genet. 2019 Jan;230:37-46. doi: 10.1016/j.cancergen.2018.11.005. Epub 2018 Nov 20. Review.

PMID:
30497985
7.

Closing the Brief Case: The Unexpected Souvenir.

Asbury K, Seville MT, Pritt B, Scotch A, Rosenthal A, Grys TE, Kelemen K.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e01414-17. doi: 10.1128/JCM.01414-17. Print 2018 Sep. No abstract available.

8.

The Brief Case: The Unexpected Souvenir.

Asbury K, Seville MT, Pritt B, Scotch A, Rosenthal A, Grys TE, Kelemen K.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e01387-17. doi: 10.1128/JCM.01387-17. Print 2018 Sep. No abstract available.

9.

Unicentric castleman disease complicated by paraneoplastic bronchiolitis obliterans and pemphigus.

Raza HA, Nokes BT, Rosenthal AC, Mangold AR, Kelemen K, Jokerst CE, Cartin-Ceba R.

Respir Med Case Rep. 2018 Aug 10;25:129-132. doi: 10.1016/j.rmcr.2018.08.002. eCollection 2018.

10.

PD-1 is highly expressed by neoplastic B-cells in Richter transformation.

Behdad A, Griffin B, Chen YH, Ma S, Kelemen K, Lu X, Chen QC.

Br J Haematol. 2019 Apr;185(2):370-373. doi: 10.1111/bjh.15514. Epub 2018 Jul 20. No abstract available.

PMID:
30028010
11.

The relationship between exercise capacity and different functional markers in pulmonary rehabilitation for COPD.

Kerti M, Balogh Z, Kelemen K, Varga JT.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 28;13:717-724. doi: 10.2147/COPD.S153525. eCollection 2018.

12.

Nivolumab-associated bone marrow necrosis.

Hilal T, Bansal P, Kelemen K, Slack J.

Ann Oncol. 2018 Feb 1;29(2):513-514. doi: 10.1093/annonc/mdx643. No abstract available.

PMID:
29351576
13.

Myeloid neoplasm with eosinophilia associated with isolated extramedullary FIP1L1/PDGFRA rearrangement.

Hilal T, Fauble V, Ketterling RP, Kelemen K.

Cancer Genet. 2018 Jan;220:13-18. doi: 10.1016/j.cancergen.2017.10.004. Epub 2017 Oct 23.

PMID:
29310833
14.

Relapse and cytogenetic evolution in myeloid neoplasms.

Ertz-Archambault N, Kelemen K.

Panminerva Med. 2017 Dec;59(4):308-319. doi: 10.23736/S0031-0808.17.03380-8. Review.

PMID:
29144072
15.

Classical Hodgkin lymphoma masquerading as chronic recurrent multifocal osteomyelitis: a case report.

Pham M, Ressler S, Rosenthal A, Kelemen K.

J Med Case Rep. 2017 Feb 18;11(1):45. doi: 10.1186/s13256-017-1224-4.

16.

Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival.

Ertz-Archambault N, Kosiorek H, Slack JL, Lonzo ML, Greipp PT, Khera N, Kelemen K.

Biol Blood Marrow Transplant. 2017 May;23(5):782-789. doi: 10.1016/j.bbmt.2017.02.003. Epub 2017 Feb 9.

17.

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Ertz-Archambault N, Kosiorek H, Taylor GE, Kelemen K, Dueck A, Castro J, Marino R, Gauthier S, Finn L, Sproat LZ, Palmer J, Mesa RA, Al-Kali A, Foran J, Tibes R.

JAMA Oncol. 2017 Jul 1;3(7):936-943. doi: 10.1001/jamaoncol.2016.6435.

18.

Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.

Kelemen K, Holden J, Johnson LJ, Davion S, Robetorye RS.

Cytometry B Clin Cytom. 2017 Jul;92(4):310-314. doi: 10.1002/cyto.b.21334. Epub 2016 Feb 5. Review.

19.

Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma.

Panchabhai S, Kelemen K, Ahmann G, Sebastian S, Mantei J, Fonseca R.

Leukemia. 2016 Apr;30(4):951-4. doi: 10.1038/leu.2015.191. Epub 2015 Jul 23. No abstract available.

PMID:
26202926
20.

Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis.

Antus B, Drozdovszky O, Barta I, Kelemen K.

Lung. 2015 Aug;193(4):597-604. doi: 10.1007/s00408-015-9739-1. Epub 2015 May 8.

PMID:
25951912
21.

Secondary Philadelphia chromosome and erythrophagocytosis in a relapsed acute myeloid leukemia after hematopoietic cell transplantation.

Kelemen K, Galani K, Conley CR, Greipp PT.

Cancer Genet. 2014 Jun;207(6):268-71. doi: 10.1016/j.cancergen.2014.05.013. Epub 2014 Jun 10.

22.

Amitriptyline-induced agranulocytosis with bone marrow confirmation.

Azadeh N, Kelemen K, Fonseca R.

Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):e183-5. doi: 10.1016/j.clml.2014.06.001. Epub 2014 Jun 11. No abstract available.

PMID:
25052053
23.

Biological Heart Rate Reduction Through Genetic Suppression of Gα(s) Protein in the Sinoatrial Node.

Lugenbiel P, Bauer A, Kelemen K, Schweizer PA, Becker R, Katus HA, Thomas D.

J Am Heart Assoc. 2012 Apr;1(2). pii: jah3-e000372. doi: 10.1161/JAHA.111.000372. Epub 2012 Apr 24.

24.

Atrioventricular delay programming in cardiac resynchronization therapy devices: fixed or adaptive? A randomized monocenter trial.

Schueler M, Voss F, Bauer A, Thomas D, Kelemen K, Katus HA, Becker R.

J Electrocardiol. 2012 Nov-Dec;45(6):783-6. doi: 10.1016/j.jelectrocard.2012.05.005. Epub 2012 Jun 20.

PMID:
22727475
25.

Exhaled breath condensate pH in patients with cystic fibrosis.

Antus B, Barta I, Csiszer E, Kelemen K.

Inflamm Res. 2012 Oct;61(10):1141-7. doi: 10.1007/s00011-012-0508-9. Epub 2012 Jun 16.

PMID:
22706320
26.

Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.

Dunlap J, Beadling C, Warrick A, Neff T, Fleming WH, Loriaux M, Heinrich MC, Kovacsovics T, Kelemen K, Leeborg N, Gatter K, Braziel RM, Press R, Corless CL, Fan G.

Hum Pathol. 2012 Dec;43(12):2167-76. doi: 10.1016/j.humpath.2012.03.002. Epub 2012 Jun 1.

PMID:
22658276
27.

Genetic suppression of Gαs protein provides rate control in atrial fibrillation.

Lugenbiel P, Thomas D, Kelemen K, Trappe K, Bikou O, Schweizer PA, Voss F, Becker R, Katus HA, Bauer A.

Basic Res Cardiol. 2012 May;107(3):265. doi: 10.1007/s00395-012-0265-5. Epub 2012 Mar 29.

PMID:
22457123
28.

[Is the determination of the defibrillation threshold in patients with an implantable cardioverter-defibrillator still required?].

Licka M, Jahn L, Kelemen K, Voss F, Trappe K, Becker R, Bikou O, Hauck M, Koch M, Katus HA, Bauer A.

Herzschrittmacherther Elektrophysiol. 2011 Dec;22(4):209-13. doi: 10.1007/s00399-011-0150-1. Epub 2011 Nov 13. German.

PMID:
22080419
29.

RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia.

Kelemen K, Kovacsovics T, Braziel R, Corless C, Beadling C, Fan G.

Leuk Lymphoma. 2012 May;53(5):999-1002. doi: 10.3109/10428194.2011.634047. Epub 2011 Dec 7. No abstract available.

PMID:
22035377
30.

Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go-related gene mutant.

Soucek R, Thomas D, Kelemen K, Bikou O, Seyler C, Voss F, Becker R, Koenen M, Katus HA, Bauer A.

Heart Rhythm. 2012 Feb;9(2):265-72. doi: 10.1016/j.hrthm.2011.09.008. Epub 2011 Sep 9.

PMID:
21907172
31.

Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model.

Bikou O, Thomas D, Trappe K, Lugenbiel P, Kelemen K, Koch M, Soucek R, Voss F, Becker R, Katus HA, Bauer A.

Cardiovasc Res. 2011 Nov 1;92(2):218-25. doi: 10.1093/cvr/cvr209. Epub 2011 Jul 28.

PMID:
21799069
32.

Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study.

Trappe K, Thomas D, Bikou O, Kelemen K, Lugenbiel P, Voss F, Becker R, Katus HA, Bauer A.

Eur Heart J. 2013 Jan;34(2):147-57. doi: 10.1093/eurheartj/ehr269. Epub 2011 Jul 23.

PMID:
21785105
33.

Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.

Dunlap J, Kelemen K, Leeborg N, Braziel R, Olson S, Press R, Huang J, Gatter K, Loriaux M, Fan G.

Am J Clin Pathol. 2011 May;135(5):709-19. doi: 10.1309/AJCPS6C8EVYCQNRM.

PMID:
21502425
34.

Exhaled breath condensate pH in lung transplant recipients with bronchiolitis obliterans syndrome.

Soter S, Kelemen K, Barta I, Valyon M, Csiszer E, Antus B.

Transplantation. 2011 Apr 15;91(7):793-7. doi: 10.1097/TP.0b013e31820d3bc3.

PMID:
21289593
35.

Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.

Kelemen K, White CR, Gatter K, Braziel RM, Fan G.

Am J Clin Pathol. 2010 Nov;134(5):739-48. doi: 10.1309/AJCP7LRRLK8SLUGE.

PMID:
20959657
36.

Immunophenotypic variations of Burkitt lymphoma.

Kelemen K, Braziel RM, Gatter K, Bakke TC, Olson S, Fan G.

Am J Clin Pathol. 2010 Jul;134(1):127-38. doi: 10.1309/AJCP93LJPTRQPDKR.

PMID:
20551277
37.

Primary mediastinal large B-cell lymphoma in HIV: report of two cases.

Kelemen K, Cao W, Peterson LC, Evens AM, Variakojis D.

J Hematop. 2009 Mar;2(1):45-9. doi: 10.1007/s12308-009-0022-3. Epub 2009 Feb 28.

38.

Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy.

Sasano T, Kelemen K, Greener ID, Donahue JK.

Heart Rhythm. 2009 Aug;6(8 Suppl):S91-7. doi: 10.1016/j.hrthm.2009.03.048. Epub 2009 Apr 1.

39.

CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease.

Kelemen K, Peterson LC, Helenowski I, Goolsby CL, Jovanovic B, Miyata S, Aranha O, Rosen ST, Winter JN, Nelson BP, Gordon LI, Evens AM.

Am J Clin Pathol. 2008 Aug;130(2):166-77. doi: 10.1309/R94MAFJY5EA4A8C3.

PMID:
18628084
40.

[Rare complication of COPD: spontaneous thoracic wall lung hernia].

Vincze K, Almuhtadi K, Kelemen K, Horváth G, Tóth L.

Orv Hetil. 2008 Mar 2;149(9):411-4. doi: 10.1556/OH.2008.28284. Hungarian.

PMID:
18292036
41.

The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome.

Kelemen K, Guitart J, Kuzel TM, Goolsby CL, Peterson LC.

Am J Clin Pathol. 2008 Jan;129(1):146-56.

PMID:
18089499
42.

Gene therapy approaches to ventricular tachyarrhythmias.

Donahue JK, Sasano T, Kelemen K.

J Electrocardiol. 2007 Nov-Dec;40(6 Suppl):S187-91.

43.

Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels.

Kelemen K, Kiesecker C, Zitron E, Bauer A, Scholz E, Bloehs R, Thomas D, Greten J, Remppis A, Schoels W, Katus HA, Karle CA.

Biochem Biophys Res Commun. 2007 Dec 21;364(3):429-35. Epub 2007 Oct 9.

PMID:
17961513
44.

Effects of protein kinase C activation on cardiac repolarization and arrhythmogenesis in Langendorff-perfused rabbit hearts.

Aydin O, Becker R, Kraft P, Voss F, Koch M, Kelemen K, Katus HA, Bauer A.

Europace. 2007 Nov;9(11):1094-8. Epub 2007 Aug 7.

PMID:
17684067
45.

Indications for predismissal testing with arrhythmia-induction in patients receiving an implantable cardioverter defibrillator.

Christ G, Becker R, Voss F, Kelemen K, Senges-Becker J, Hauck M, Schoels W, Bald I, Katus H, Bauer A.

Clin Res Cardiol. 2007 Sep;96(9):613-20. Epub 2007 Jun 27.

PMID:
17593312
46.

Role of KATP channels in repetitive induction of ventricular fibrillation.

Bauer A, Becker R, Dreyhaupt J, Voss F, Kraft P, Kelemen K, Senges-Becker JC, Katus HA, Schoels W.

Europace. 2007 Mar;9(3):154-61. Epub 2007 Jan 25.

PMID:
17255149
47.

Effect of testosterone loading on the kinetic of faecal testosterone excretion in mallards.

Szoke Z, Váradi E, Kelemen K, Biczó A, Péczely P.

Acta Biol Hung. 2006 Mar;57(1):13-21.

PMID:
16646521
48.

[Efficiency potential in the pacemaker/implantable cardioverter defibrillator outpatient clinic].

Bauer A, Bauer J, Bauer M, Kelemen K, Voss F, Senges-Becker J, Weretka S, Katus HA, Becker R.

Herzschrittmacherther Elektrophysiol. 2006 Mar;17(1):26-34. German.

PMID:
16547657
49.

The new selective I(Ks)-blocking agent HMR 1556 restores sinus rhythm and prevents heart failure in pigs with persistent atrial fibrillation.

Bauer A, Koch M, Kraft P, Becker R, Kelemen K, Voss F, Senges JC, Gerlach U, Katus HA, Schoels W.

Basic Res Cardiol. 2005 May;100(3):270-8. Epub 2005 Apr 1.

PMID:
15795798
50.

The role of T cells in beta cell damage in NOD mice and humans.

Kelemen K.

Adv Exp Med Biol. 2004;552:117-28. Review.

PMID:
15622961

Supplemental Content

Loading ...
Support Center